Taysha Gene Therapies, Inc.

Historical 13F Holders

Symbol
TSHA
CUSIP
877619106
All holders as of
Q1 2025
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 130 167 M $232 M
2024 Q4 133 167 M $289 M
2024 Q3 124 160 M $326 M
2024 Q2 112 169 M $378 M
2024 Q1 116 151 M $432 M
2023 Q4 95 130 M $231 M
2023 Q3 68 130 M $411 M
2023 Q2 42 13.7 M $9.05 M
2023 Q1 47 16.7 M $13.3 M
2022 Q4 57 19.5 M $44.0 M
2022 Q3 57 13.9 M $27.0 M
2022 Q2 61 14.7 M $54.7 M
2022 Q1 75 17.0 M $111 M
2021 Q4 66 18.5 M $216 M
2021 Q3 49 19.4 M $362 M
2021 Q2 51 18.6 M $395 M
2021 Q1 49 18.1 M $368 M
2020 Q4 53 18.0 M $475 M
2020 Q3 47 16.6 M $367 M